Simone Cesaro/aileonlus.org
Apr 8, 2025, 16:56
Simone Cesaro: Recipient CMV positivity predicts better outcomes in pediatric stem cell transplant
Simone Cesaro, Director Pediatric Hematology Oncology Unit at Integrated University Hospital of Verona and Founding Board Member at European Conference on Infections on Leukemia and Stem Cell Transplantations, shared a post on LinkedIn:
“In pediatric stem cell transplant, positive CMV serology status of the recipient and of the donor predicts a better outcome, while no influence was found by positive or negative CMV serology of the donor if recipient CMV serology is negative.”
More posts featuring Simone Cesaro.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 9, 2025, 19:54
Jun 9, 2025, 19:26
Jun 9, 2025, 18:29